MoneyWorks4Me

Kopran - Quaterly Results

29 Jul 2025 Evaluate
The quarter ended June 2025 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 513.35 millions.The Net Profit of the company registered a slight decline of -17.15% to Rs. 35.18  millions from Rs. 42.46 millions.Operating Profit reported a sharp decline to 68.68 millions from 74.01 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 513.35 496.07 3.48 513.35 496.07 3.48 2710.10 3374.56 -19.69
Other Income 17.98 21.20 -15.19 17.98 21.20 -15.19 59.04 167.11 -64.67
PBIDT 68.68 74.01 -7.20 68.68 74.01 -7.20 445.60 536.37 -16.92
Interest 10.42 6.92 50.58 10.42 6.92 50.58 37.66 45.01 -16.33
PBDT 58.26 67.09 -13.16 58.26 67.09 -13.16 407.94 491.36 -16.98
Depreciation 12.19 11.97 1.84 12.19 11.97 1.84 49.99 46.20 8.20
PBT 46.07 55.12 -16.42 46.07 55.12 -16.42 357.95 445.16 -19.59
TAX 10.89 12.66 -13.98 10.89 12.66 -13.98 89.38 98.79 -9.53
Deferred Tax 0.09 -1.33 -106.77 0.09 -1.33 -106.77 3.06 -2.03 -250.74
PAT 35.18 42.46 -17.15 35.18 42.46 -17.15 268.57 346.37 -22.46
Equity 482.11 482.11 0.00 482.11 482.11 0.00 482.86 482.11 0.16
PBIDTM(%) 13.38 14.92 -10.33 13.38 14.92 -10.33 16.44 15.89 3.45
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..